Constellation Pharmaceuticals, Inc. EPS - Earnings per Share 2018-2021 | CNST
Constellation Pharmaceuticals, Inc. eps - earnings per share from 2018 to 2021. Eps - earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
| Constellation Pharmaceuticals, Inc. Annual EPS |
| 2020 |
$-2.81 |
| 2019 |
$-3.04 |
| 2018 |
$-5.00 |
| 2017 |
$-56.10 |
| 2016 |
$-53.19 |
| Constellation Pharmaceuticals, Inc. Quarterly EPS |
| 2021-03-31 |
$-0.84 |
| 2020-12-31 |
$-0.79 |
| 2020-09-30 |
$-0.71 |
| 2020-06-30 |
$-0.70 |
| 2020-03-31 |
$-0.61 |
| 2019-12-31 |
$-0.67 |
| 2019-09-30 |
$-0.82 |
| 2019-06-30 |
$-0.80 |
| 2019-03-31 |
$-0.75 |
| 2018-12-31 |
$18.21 |
| 2018-09-30 |
$-0.81 |
| 2018-06-30 |
$-9.96 |
| 2018-03-31 |
$-12.44 |
| 2017-09-30 |
$-15.18 |
| 2017-06-30 |
$-12.81 |
